152 related articles for article (PubMed ID: 35953860)
1. Hexokinase 2 promoted cell motility and proliferation by activating Akt1/p-Akt1 in human ovarian cancer cells.
Tian X; Liu D; Zuo X; Sun X; Wu M; Li X; Teng Y
J Ovarian Res; 2022 Aug; 15(1):92. PubMed ID: 35953860
[TBL] [Abstract][Full Text] [Related]
2. Hexokinases 2 promoted cell motility and distant metastasis by elevating fibronectin through Akt1/p-Akt1 in cervical cancer cells.
Chen Q; Li L; Liu X; Feng Q; Zhang Y; Zheng P; Cui N
Cancer Cell Int; 2021 Nov; 21(1):600. PubMed ID: 34758823
[TBL] [Abstract][Full Text] [Related]
3. Expression of hexokinase 2 in epithelial ovarian tumors and its clinical significance in serous ovarian cancer.
Jin Z; Gu J; Xin X; Li Y; Wang H
Eur J Gynaecol Oncol; 2014; 35(5):519-24. PubMed ID: 25423696
[TBL] [Abstract][Full Text] [Related]
4. SPI1 involvement in malignant melanoma pathogenesis by regulation of HK2 through the AKT1/mTOR pathway.
Liu C; Qiu X; Gao J; Gong Z; Zhou X; Luo H; Geng X
J Cell Mol Med; 2023 Sep; 27(18):2675-2683. PubMed ID: 37539493
[TBL] [Abstract][Full Text] [Related]
5. [The role of hexokinase 2 in the metastasis of hepatocellular carcinoma cells].
Geng XL; Long WH; Hai J; Zhang Y; Zheng W; Zhang ZY; Du LX
Zhonghua Zhong Liu Za Zhi; 2016 Oct; 38(10):739-742. PubMed ID: 27784456
[No Abstract] [Full Text] [Related]
6. Long non-coding RNA HAL suppresses the migration and invasion of serous ovarian cancer by inhibiting EMT signaling pathway.
Wu K; Li L; Li L; Wang D
Biosci Rep; 2020 Mar; 40(3):. PubMed ID: 32039453
[TBL] [Abstract][Full Text] [Related]
7. UBE2S promotes the development of ovarian cancer by promoting PI3K/AKT/mTOR signaling pathway to regulate cell cycle and apoptosis.
Zhang M; Liu Y; Yin Y; Sun Z; Wang Y; Zhang Z; Li F; Chen X
Mol Med; 2022 Jun; 28(1):62. PubMed ID: 35658829
[TBL] [Abstract][Full Text] [Related]
8. Hexokinase 2 confers resistance to cisplatin in ovarian cancer cells by enhancing cisplatin-induced autophagy.
Zhang XY; Zhang M; Cong Q; Zhang MX; Zhang MY; Lu YY; Xu CJ
Int J Biochem Cell Biol; 2018 Feb; 95():9-16. PubMed ID: 29247711
[TBL] [Abstract][Full Text] [Related]
9. A gain of function mutation in AKT1 increases hexokinase 2 and diminishes oxidative stress in meningioma.
Singh S; Lathoria K; Umdor SB; Singh J; Suri V; Sen E
Cytokine; 2024 Apr; 176():156535. PubMed ID: 38325141
[TBL] [Abstract][Full Text] [Related]
10. FOXM1 promotes reprogramming of glucose metabolism in epithelial ovarian cancer cells via activation of GLUT1 and HK2 transcription.
Wang Y; Yun Y; Wu B; Wen L; Wen M; Yang H; Zhao L; Liu W; Huang S; Wen N; Li Y
Oncotarget; 2016 Jul; 7(30):47985-47997. PubMed ID: 27351131
[TBL] [Abstract][Full Text] [Related]
11. Putative stem cells and epithelial-mesenchymal transition revealed in sections of ovarian tumor in patients with serous ovarian carcinoma using immunohistochemistry for vimentin and pluripotency-related markers.
Kenda Suster N; Smrkolj S; Virant-Klun I
J Ovarian Res; 2017 Feb; 10(1):11. PubMed ID: 28231820
[TBL] [Abstract][Full Text] [Related]
12. Hexokinase 2 Promotes Cell Proliferation and Tumor Formation through the Wnt/β-catenin Pathway-mediated Cyclin D1/c-myc Upregulation in Epithelial Ovarian Cancer.
Liu X; Zuo X; Sun X; Tian X; Teng Y
J Cancer; 2022; 13(8):2559-2569. PubMed ID: 35711830
[No Abstract] [Full Text] [Related]
13. Enrichment of ovarian cancer stem-like cells is associated with epithelial to mesenchymal transition through an miRNA-activated AKT pathway.
Luo X; Dong Z; Chen Y; Yang L; Lai D
Cell Prolif; 2013 Aug; 46(4):436-46. PubMed ID: 23869765
[TBL] [Abstract][Full Text] [Related]
14. Follicle-stimulating hormone induced epithelial-mesenchymal transition of epithelial ovarian cancer cells through follicle-stimulating hormone receptor PI3K/Akt-Snail signaling pathway.
Yang Y; Zhang J; Zhu Y; Zhang Z; Sun H; Feng Y
Int J Gynecol Cancer; 2014 Nov; 24(9):1564-74. PubMed ID: 25340291
[TBL] [Abstract][Full Text] [Related]
15. RHBDD1 promotes proliferation, migration, invasion and EMT in renal cell carcinoma via the EGFR/AKT signaling pathway.
Li M; Cai L; Wang X; Yu Y; Jian W; Bao G; Gao Z; Guo J; Zhang J; Li C; Zhang C
Mol Med Rep; 2021 Dec; 24(6):. PubMed ID: 34581421
[TBL] [Abstract][Full Text] [Related]
16. Hexokinase 2 overexpression promotes the proliferation and survival of laryngeal squamous cell carcinoma.
Chen J; Zhang S; Li Y; Tang Z; Kong W
Tumour Biol; 2014 Apr; 35(4):3743-53. PubMed ID: 24363061
[TBL] [Abstract][Full Text] [Related]
17. Long non-coding RNA DLEU2 drives EMT and glycolysis in endometrial cancer through HK2 by competitively binding with miR-455 and by modulating the EZH2/miR-181a pathway.
Dong P; Xiong Y; Konno Y; Ihira K; Kobayashi N; Yue J; Watari H
J Exp Clin Cancer Res; 2021 Jun; 40(1):216. PubMed ID: 34174908
[TBL] [Abstract][Full Text] [Related]
18. Effect of MicroRNA-210 on the Growth of Ovarian Cancer Cells and the Efficacy of Radiotherapy.
Zhao Y; Liu S; Wen Y; Zhong L
Gynecol Obstet Invest; 2021; 86(1-2):71-80. PubMed ID: 33260174
[TBL] [Abstract][Full Text] [Related]
19. Enhanced antitumor effects of follicle-stimulating hormone receptor-mediated hexokinase-2 depletion on ovarian cancer mediated by a shift in glucose metabolism.
Zhang M; Liu Q; Zhang M; Cao C; Liu X; Zhang M; Li G; Xu C; Zhang X
J Nanobiotechnology; 2020 Nov; 18(1):161. PubMed ID: 33160373
[TBL] [Abstract][Full Text] [Related]
20. Cysteine-Rich Intestinal Protein 1 Served as an Epithelial Ovarian Cancer Marker via Promoting Wnt/
Liu Y; Li W; Luo J; Wu Y; Xu Y; Chen T; Zhang W; Fu F
Dis Markers; 2021; 2021():3566749. PubMed ID: 34413913
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
